Opportunity Information: Apply for CDC RFA PS15 1506
Apply for CDC RFA PS15 1506
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.940 HIV Prevention ActivitiesHealth Department Based.
- This funding opportunity was created on Apr 14, 2015 and posted on Mar 31, 2015.
- Applicants must submit their applications by Jun 1, 2015 Applications must be submitted electronically no later than 1159 p.m., ET, on June 1, 2015.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $50,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $7,000,000.00 in funding.
- The number of recipients for this funding is limited to 24 candidate(s).
- Eligible applicants include: City or township governments State governments County governments.
- Eligibility for Category 1 (PrEP Support Demonstration Projects Targeting MSM and Transgender Persons at Substantial Risk of Acquiring HIV) is limited to health departments whose jurisdiction includes one or more of the thirty two (32) MSAs/MDs in which there are greater than 3,000 MSM living with diagnosed HIV by year end 2010 (2011 MSA report, table 6b, published Oct 2013). Eligibility for Category 2 (Data to Care Demonstration Projects That Use Surveillance Data Sources to Identify MSM and Transgender Persons Not in HIV Care) is limited to health departments that are eligible to apply for Category 1 and have complete reporting of all CD4 cell count and HIV viral load results. Complete laboratory reporting of CD4 and HIV viral load test results is defined as follows The jurisdictionrsquos laws/regulations require the reporting of all CD4 and viral load results to the state/city health department A minimum of 95 of HIV related test results from laboratories that perform HIV related testing for each area are being reported to the state/city health department The jurisdiction is reporting at least 95 of all CD4 and viral load test results to CDC as of December 31, 2013 (as outlined in the 2012 Monitoring Report, published in November 2014). States that have local health departments directly funded by CDC are not eligible to apply for the MSAs/MDs that contain locally funded health departments within the state. State health departments with one eligible MSA/MD are required to work in the specified eligible MSA/MD. States that have more than one eligible MSA/MD may elect to work in all or a reduced number of eligible MSAs or MDs, in order of prevalence.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (CDC RFA PS15-1506) was a discretionary cooperative agreement designed to help state and local health departments reduce new HIV infections and strengthen engagement in HIV medical care, with a clear focus on men who have sex with men (MSM) and transgender persons, especially people of color. The program set out to fund demonstration projects that put proven strategies into practice in jurisdictions with a high burden of HIV among MSM, recognizing that these populations experience disproportionate HIV impact and that targeted, health-department-led approaches can improve prevention and care outcomes at scale.
The FOA supported two related project categories. Category 1 funded PrEP Support Demonstration Projects aimed at MSM and transgender people at substantial risk of acquiring HIV. In practical terms, these projects were meant to help health departments build or strengthen systems that identify people who could benefit from pre-exposure prophylaxis (PrEP), link them to PrEP services, and support persistence and adherence over time. While the priority population was MSM and transgender persons at highest risk, the announcement also allowed PrEP-related services to extend to other individuals at substantial risk for HIV when appropriate, as long as the primary emphasis remained on the priority groups specified in the FOA.
Category 2 funded Data to Care Demonstration Projects, which use HIV surveillance and related data sources to identify people with diagnosed HIV who are not in care or not virally suppressed, then support efforts to re-engage them in treatment and ongoing care. The category emphasized using surveillance-driven approaches to find MSM and transgender persons who have fallen out of care or who have ongoing risk behaviors, with the goal of improving retention in care and achieving viral suppression. As with Category 1, programs could also serve other people living with HIV who were not virally suppressed or were not engaged in care, but the required priority remained MSM and transgender persons, particularly persons of color.
Funding was substantial and structured to enable meaningful public health implementation. CDC anticipated up to 24 awards, with an estimated total funding amount of $50,000,000. Individual awards ranged from a floor of $500,000 to a ceiling of $7,000,000. There was no cost-sharing or matching requirement, which lowered barriers for health departments to apply and implement. The CFDA listing associated with the program was 93.940 (HIV Prevention Activities Health Department Based), reflecting the prevention and public health infrastructure orientation of the work.
Eligibility was limited to U.S. governmental health departments at the city/township, county, or state level, and it was further narrowed by epidemiologic and data-capacity requirements tied to the two categories. For Category 1, only health departments whose jurisdictions included one or more of 32 specific metropolitan statistical areas or metropolitan divisions (MSAs/MDs) were eligible. Those MSAs/MDs were defined by having more than 3,000 MSM living with diagnosed HIV as of year-end 2010, based on a CDC-referenced MSA report (table 6b, published October 2013). For Category 2, applicants had to meet Category 1 eligibility and also demonstrate robust laboratory reporting completeness for CD4 and HIV viral load results. Specifically, jurisdictions needed laws or regulations requiring reporting of all CD4 and viral load results to the state/city health department, evidence that at least 95% of HIV-related test results from relevant laboratories were being reported to the health department, and evidence that at least 95% of all CD4 and viral load test results were being reported to CDC as of December 31, 2013 (as described in a monitoring report published in November 2014). These conditions reflected the reality that Data to Care depends on timely, near-complete surveillance laboratory data to accurately identify people who are out of care or not virally suppressed.
The FOA also included jurisdictional coordination rules meant to avoid duplication where CDC already funded local entities. States with locally funded health departments were not eligible to apply for the MSAs/MDs that contained those locally funded departments. State health departments with one eligible MSA/MD were required to work in that specific eligible area. States with more than one eligible MSA/MD could choose to work in all eligible areas or select a reduced number, prioritized in order of HIV prevalence, which signaled CDCs expectation that resources should be directed where they could have the largest impact.
Administratively, the opportunity was posted March 31, 2015, with applications due electronically by 11:59 p.m. Eastern Time on June 1, 2015, and it was archived July 1, 2015. The sponsor agency was the Centers for Disease Control and Prevention. A named contact for access issues was provided (Carolyn Leighton, CYG8@cdc.gov), indicating applicants could request support if they had trouble obtaining the full announcement materials.
Frequently Asked Questions (FAQs) - CDC RFA PS15-1506
What is CDC RFA PS15-1506?
CDC RFA PS15-1506 was a CDC discretionary cooperative agreement intended to help state and local health departments reduce new HIV infections and strengthen engagement in HIV medical care. The opportunity emphasized demonstration projects that put proven strategies into practice, particularly in jurisdictions with a high burden of HIV among men who have sex with men (MSM).
What populations were the primary focus of this funding opportunity?
The primary focus was on MSM and transgender persons, especially people of color, reflecting the disproportionate impact of HIV in these communities and the intent to support targeted, health-department-led approaches.
What were the two project categories supported by the FOA?
The FOA supported two related categories: (1) Category 1: PrEP Support Demonstration Projects and (2) Category 2: Data to Care Demonstration Projects.
What is Category 1 (PrEP Support Demonstration Projects) intended to do?
Category 1 funded projects designed to help health departments build or strengthen systems to identify individuals who could benefit from pre-exposure prophylaxis (PrEP), link them to PrEP services, and support persistence and adherence over time. The primary emphasis was on MSM and transgender people at substantial risk of acquiring HIV.
Can Category 1 projects serve people other than MSM and transgender persons?
Yes. The announcement allowed PrEP-related services to extend to other individuals at substantial risk for HIV when appropriate, as long as the primary emphasis remained on the priority groups specified in the FOA (MSM and transgender persons, especially people of color).
What is Category 2 (Data to Care Demonstration Projects) intended to do?
Category 2 funded projects that use HIV surveillance and related data sources to identify people with diagnosed HIV who are not in care or not virally suppressed, then support efforts to re-engage them in treatment and ongoing care. The intent was to improve retention in care and achieve viral suppression, particularly for MSM and transgender persons.
Can Category 2 projects serve people living with HIV outside the primary priority groups?
Yes. Programs could also serve other people living with HIV who were not virally suppressed or not engaged in care, but the required priority remained MSM and transgender persons, particularly persons of color.
How many awards did CDC anticipate making under this opportunity?
CDC anticipated making up to 24 awards.
What was the estimated total funding amount for the program?
The estimated total funding amount was $50,000,000.
What was the award size range for individual recipients?
Individual awards ranged from a minimum (floor) of $500,000 to a maximum (ceiling) of $7,000,000.
Was cost sharing or matching required?
No. There was no cost-sharing or matching requirement.
What CFDA listing was associated with this program?
The CFDA listing associated with the program was 93.940 (HIV Prevention Activities Health Department Based).
Who was eligible to apply?
Eligibility was limited to U.S. governmental health departments at the city/township, county, or state level, with additional epidemiologic and data-capacity requirements depending on the project category.
What were the eligibility requirements for Category 1?
For Category 1, only health departments whose jurisdictions included one or more of 32 specified metropolitan statistical areas or metropolitan divisions (MSAs/MDs) were eligible. These MSAs/MDs were identified as having more than 3,000 MSM living with diagnosed HIV as of year-end 2010, based on a CDC-referenced MSA report (table 6b, published October 2013).
What additional eligibility requirements applied to Category 2?
For Category 2, applicants had to meet Category 1 eligibility and also demonstrate strong laboratory reporting completeness for CD4 and HIV viral load results. Requirements included: (1) laws or regulations requiring reporting of all CD4 and viral load results to the state/city health department, (2) evidence that at least 95% of HIV-related test results from relevant laboratories were being reported to the health department, and (3) evidence that at least 95% of all CD4 and viral load test results were being reported to CDC as of December 31, 2013 (as described in a monitoring report published in November 2014).
Why did Category 2 require near-complete laboratory reporting?
The FOA reflected that Data to Care depends on timely, near-complete surveillance laboratory data to accurately identify people who are out of care or not virally suppressed.
Were there any jurisdictional rules to prevent duplication of funding?
Yes. The FOA included coordination rules to avoid duplication where CDC already funded local entities. States with locally funded health departments were not eligible to apply for the MSAs/MDs that contained those locally funded departments.
If a state had one eligible MSA/MD, did the FOA require work in that specific area?
Yes. State health departments with one eligible MSA/MD were required to work in that specific eligible area.
If a state had more than one eligible MSA/MD, could it choose where to work?
Yes. States with more than one eligible MSA/MD could choose to work in all eligible areas or select a reduced number. The FOA indicated that selected areas should be prioritized in order of HIV prevalence.
When was the funding opportunity posted?
The opportunity was posted on March 31, 2015.
What was the application deadline?
Applications were due electronically by 11:59 p.m. Eastern Time on June 1, 2015.
When was the opportunity archived?
The opportunity was archived on July 1, 2015.
Which federal agency sponsored this FOA?
The sponsor agency was the Centers for Disease Control and Prevention (CDC).
Who was listed as a contact for access issues related to the announcement materials?
The FOA provided a named contact for access issues: Carolyn Leighton (CYG8@cdc.gov).
Browse more opportunities from the same category: Health
Next opportunity: BJA FY 15 Justice Reinvestment Initiative Assessment Technical Assistance and Maximizing Local Reforms
Previous opportunity: Ever Restoration Meeting 2015
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 1506
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 1506) also looked into and applied for these:
| Funding Opportunity |
|---|
| Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection Apply for CDC RFA PS15 1510 Funding Number: CDC RFA PS15 1510 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
| Request for Information for RFI 674 15 RHAP 001 Apply for RFI 674 15 RHAP 001 Funding Number: RFI 674 15 RHAP 001 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Research and Design (HIVRAD) Program (P01) Apply for PAR 15 164 Funding Number: PAR 15 164 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Training and Technical Assistance Cooperative Agreements (NCAs) Apply for HRSA 15 140 Funding Number: HRSA 15 140 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 15 165 Funding Number: PAR 15 165 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tuberculosis Health Action Learning Initiative (THALI) Apply for RFA 386 15 000001 Funding Number: RFA 386 15 000001 Agency: India USAID New Delhi Category: Health Funding Amount: $9,500,000 |
| NIBIB Research Education Programs for Residents and Clinical Fellows (R25) Apply for PAR 15 167 Funding Number: PAR 15 167 Agency: National Institutes of Health Category: Health Funding Amount: $70,000 |
| PPHF 2015 Cooperative Agreements for State Sponsored Youth Suicide Prevention and Early Intervention (PPHF 2015) Apply for SM 15 004 Funding Number: SM 15 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $736,000 |
| Alzheimers Drug Development Program (U01) Apply for PAR 15 174 Funding Number: PAR 15 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| PPHF 2015 Empowering Older Adults and Adults with Disabilities through Chronic Disease Self Management Education Programs Financed Solely by 2015 Prevention and Public Health Funds (PPHF 2015) Apply for HHS 2015 ACL AOA CS 0094 Funding Number: HHS 2015 ACL AOA CS 0094 Agency: Administration for Community Living Category: Health Funding Amount: $900,000 |
| Epicenters for the Prevention of Healthcare Associated Infections (HAI) Cycle II Apply for RFA CK 15 004 Funding Number: RFA CK 15 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,200,000 |
| Native Hawaiian Health Care Improvement Act Apply for HRSA 15 017 Funding Number: HRSA 15 017 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01) Apply for PAR 15 172 Funding Number: PAR 15 172 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co Infections (R01) Apply for RFA DE 16 002 Funding Number: RFA DE 16 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pre Application for Collaborative Innovation Award, CTSA Program (X02) Apply for PAR 15 173 Funding Number: PAR 15 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42) Apply for RFA AT 16 004 Funding Number: RFA AT 16 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R43/R44) Apply for RFA AT 16 003 Funding Number: RFA AT 16 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01) Apply for PAR 15 175 Funding Number: PAR 15 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Center for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases and Tuberculosis Prevention (NCHHSTP) Public Health Conference Support Apply for CDC RFA PS15 1507 Funding Number: CDC RFA PS15 1507 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| Developing professional training programs to increase capacity for effective global health response to humanitarian emergencies Apply for CDC RFA GH15 1624 Funding Number: CDC RFA GH15 1624 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 1506", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.